Search

everythinglearnresearchcommunity

for

Search:↓

Fenoterol treatment causes increased hair growth due to higher metabolism in hair follicles, not hormones.

The method detected sex hormones in some health supplements, with one containing banned testosterone.

SHPro® improved urinary symptoms and erectile function in men and is safe.

The "Stimufit" tincture is safe and effective for treating hair loss.

The TrichoConcept™ line is effective for personalized hair loss treatments.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Using finasteride with TIP extends time off period for prostate cancer patients.

Equilibrium dialysis can accurately measure testosterone levels when lab results are inconsistent.

The supplement did not work better than a placebo for hair loss in women over 60.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

Estetrol may help prevent hair loss and support hair growth in women.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

The FDA rejected a testosterone drug again due to safety concerns.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

GV-350 improves hair growth and quality of life in iron-deficient women without side effects.

Hair analysis can detect testosterone in horses after drug administration.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

The FDA did not approve a testosterone drug because of safety concerns.

The method effectively showed that the two exemestane preparations are bioequivalent.

Estetrol helps keep scalp hair in the growth phase longer and improves hair follicle health by affecting the hair root and increasing stem cells.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

The β-sitosterol hair gel is effective and promising for treating hair loss.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Daily subcutaneous testosterone effectively restores testosterone levels in men.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.